Background-18 F-Galacto-RGD is a positron emission tomography (PET) tracer binding to ␣ v ␤ 3 integrin that is expressed by macrophages and endothelial cells in atherosclerotic lesions. Therefore, we evaluated 18 F-galacto-RGD for imaging vascular inflammation by studying its uptake into atherosclerotic lesions of hypercholesterolemic mice in comparison to deoxyglucose. Methods and results-Hypercholesterolemic LDLR Ϫ/Ϫ ApoB 100/100 mice on a Western diet and normally fed adult C57BL/6 control mice were injected with 18 F-galacto-RGD and 3 H-deoxyglucose followed by imaging with a small animal PET/CT scanner. The aorta was dissected 2 hours after tracer injection for biodistribution studies, autoradiography, and histology. Biodistribution of 18 F-galacto-RGD was higher in the atherosclerotic than in the normal aorta. Autoradiography demonstrated focal 18 F-galacto-RGD uptake in the atherosclerotic plaques when compared with the adjacent normal vessel wall or adventitia. Plaque-to-normal vessel wall ratios were comparable to those of deoxyglucose. Although angiogenesis was not detected, 18 F-galacto-RGD uptake was associated with macrophage density and deoxyglucose accumulation in the plaques. Binding to atherosclerotic lesions was efficiently blocked in competition experiments. In vivo imaging visualized 18 F-galacto-RGD uptake colocalizing with calcified lesions of the aortic arch as seen in CT angiography. Conclusions-18 F-Galacto-RGD demonstrates specific uptake in atherosclerotic lesions of mouse aorta. In this model, its uptake was associated with macrophage density. 18 F-Galacto-RGD is a potential tracer for noninvasive imaging of inflammation in atherosclerotic lesions. (Circ Cardiovasc Imaging. 2009;2:331-338.)
T he majority of myocardial infarctions and sudden cardiac deaths result from the rupture of atherosclerotic plaques that often had not caused significant luminal obstruction or symptoms before the acute event. 1, 2 Inflammation is considered as a key feature of plaques at high risk of rupture. Circulating monocytes are progressively recruited to plaques, where they differentiate into macrophages and cholesterolfilled foam cells constituting the main component of the plaque lipid core. Macrophages secrete inflammatory cytokines as well as produce proteolytic enzymes that can weaken the protective fibrous cap of the plaque and thus make it vulnerable to rupture. 3, 4 The prevalence of macrophages is high in ruptured plaques and plaques of patients with acute coronary syndromes. 5, 6 More recently, intraplaque angiogen-esis by proliferation of medial vasa vasorum has also been implicated in rapid plaque growth and plaque rupture. 7 The fragile and leaky structure of neovasculature may lead to extravasation of red blood cells in the plaques with subsequent intraplaque hemorrhage that can predispose to plaque rupture. Therefore, noninvasive imaging of inflammation and angiogenesis within atherosclerotic lesions may be useful to predict future risk of plaque rupture and allow monitoring of antiatherosclerotic therapies that are essential for efficient prevention of the acute events.
Clinical Perspective on p 338
Recent experimental and human studies have provided evidence that positron emission tomography (PET) imaging using fluorine-18-fluorodeoxyglucose ( 18 F-FDG), a glucose analogue that is taken up by the metabolically active macrophages, could provide an index of inflammation in atherosclerotic lesions. 8 -10 However, because of the intense uptake of 18 F-FDG in the myocardium and the dependence of its uptake on metabolic conditions, other tracers of plaque inflammation and vulnerability are needed. 18 F-Galacto-RGD is a peptide tracer for PET imaging that binds with high specificity to ␣ v ␤ 3 integrin, a cell surface glycoprotein receptor that is highly expressed during angiogenesis. 18 F-Galacto-RGD PET has been extensively validated for imaging the level of ␣ v ␤ 3 integrin expression in tumors. [11] [12] [13] In atherosclerotic lesions, both macrophages and activated endothelial cells can express high levels of ␣ v ␤ 3 integrin. 14, 15 Therefore, ␣ V ␤ 3 expression is a potential marker of inflammation and angiogenesis in atherosclerotic lesions. MRI of ␣ V ␤ 3 integrin-targeted paramagnetic nanoparticles demonstrated signal enhancement in the rabbit aorta with early atherosclerotic changes. 16 However, the value of 18 F-galacto-RGD PET in imaging atherosclerosis and vascular inflammation remains unknown.
We sought to evaluate 18 F-galacto-RGD for imaging vascular inflammation by studying its uptake in the atherosclerotic mouse aorta. We also compared 18 F-galacto-RGD uptake with accumulation of tritiated deoxyglucose ( 3 H-DG), an in vitro analogue of 18 F-FDG. Biodistribution of 18 F-galacto-RGD in atherosclerotic mice was compared with healthy control mice. Uptake of the tracers in the vessel wall was studied by autoradiography of tissue sections and compared with histology. Specificity was confirmed by competition experiments. Finally, uptake of 18 F-galacto-RGD was imaged by PET coregistered with a CT angiogram using a small animal scanner.
Methods

Animal Model and Tracers
The study group consisted of 12 male hypercholesterolemic LDLR Ϫ/Ϫ ApoB 100/100 mice (double knock-out mice deficient of LDL receptor and ApoB48) 17, 18 and 11 male C57BL/6N control mice. The hypercholesterolemic mice were kept on a Western diet (TD88173, Harlan Teklad) from 8 to 38 weeks (mean, 22 weeks) preceding the examinations to induce atherosclerosis. Atherosclerotic mice were investigated at the age of 54 to 70 weeks (mean, 64 weeks) and controls at the age of 18 to 37 weeks (mean, 26 weeks). Atherosclerotic mice weighed 40Ϯ6 g (meanϮSD) and controls, 30Ϯ3 g.
Synthesis of 18 F-galacto-RDG was performed as described earlier. 19 Anesthetized LDLR Ϫ/Ϫ ApoB 100/100 and control mice were injected with an average of 27.6 MBq and 25.7 MBq of 18 F-galacto-RGD in the tail vein, respectively. Six hypercholesterolemic and 2 controls were simultaneously injected with 3.7 MBq of 3 H-DG (2-Deoxy-D-[1-3 H]glucose, GE Healthcare, Buckinghamshire, UK). The study protocols were approved by the regional governmental commission of animal protection of Bavaria (Regierung von Oberbayern, Munich, Germany).
Biodistribution Studies
Eight LDLR Ϫ/Ϫ ApoB 100/100 mice and 7 controls were euthanized 2 hours after injection and the aorta, and other organs were prepared for analysis of 18 F-galacto-RGD biodistribution. The thoracic aorta was dissected and blood was removed with saline. Tissue samples from the apex of the heart, liver, kidney, abdominal fat, femoral muscle, and injection site (the tail) were dissected and weighed, and their radioactivity was measured with a ␥ counter together with the aorta and a blood sample (Wallac Wizard, PerkinElmer). Background counts were subtracted, the radioactivity decay was corrected to the time of injection, and the dose remaining in the tail was compensated. The radioactivity that accumulated in the tissue samples over a 2-hour period after 18 F-galacto-RGD injection was expressed as a percentage of the injected dose per gram of tissue (%ID/g).
Autoradiography
The uptake of 18 F-galacto-RGD and 3 H-DG to the vessel wall was studied by digital autoradiography of aortic tissue sections as previously described 20, 21 in 8 LDLR Ϫ/Ϫ ApoB 100/100 mice and 5 controls injected with 18 F-galacto-RGD and 6 LDLR Ϫ/Ϫ ApoB 100/100 mice and 2 controls injected with both tracers. The dissected aortas were frozen in mounting medium, cut in sequential, longitudinal 20and 8-m sections at Ϫ20°C (Microtom-Kryostat HM500 OM, Microm Laborgerate GmbH), and thaw-mounted onto microscope slides. For measurement of the accumulated 18 F activity, the 20-m aorta sections were apposed to an imaging plate (Fuji Imaging Plate BAS-MS2040, Fuji Photo Film Co Ltd, Tokyo, Japan). After overnight exposure, the imaging plates were scanned with the Fuji Analyzer FLA-2000. For dual tracer autoradiography, the sections were stored for 1 week, exposed again for 14 days (Fuji Imaging Plate BAS-TR2025), and scanned to measure accumulated 3 H activity.
The images were analyzed for count densities (PSL/mm 2 ) with an image analysis program (Tina 2.1, Raytest Isotopenmessgeräte, GmbH, Straubenhardt, Germany). After careful coregistration of autoradiography and hematoxylin and eosin-stained histological images, 3 types of regions of interest (ROI) were defined according to morphology in 3 to 7 sections from each mouse: (1) normal vessel wall (no lesion formation, nϭ74), (2) plaque (excluding media, nϭ150), and (3) adventitia (nϭ99). The same template of ROIs was used in the 18 F-and 3 H-autoradiograms to compare the activity in exactly the same regions. The background area count densities were subtracted from the image data and the results of each mouse were normalized for injected dose and decay. The coefficient of variation of repeated analyses was 4.5% (nϭ6 mice).
In Vitro Binding of 18 F-Galacto-RGD in Mouse Aorta Sections
In vitro binding and displacement studies were performed as described earlier. 21 Briefly, 20-m sections of atherosclerotic mouse aorta were warmed to room temperature (RT), preincubated for 5 minutes at RT in PBS buffer, and incubated with 10 nM 18 F-galacto-RGD (specific activity range, 40 to 100 TBq/mmol) in PBS buffer on a spot for 30 minutes at RT. Serial sections were incubated in the presence of 10 mmol of competing unlabeled cyclic RGD pentapeptide (Cilenqitide, Merck KGaA, Darmstadt, Germany). After incubation, the slides were washed twice for 5 minutes with PBS, rinsed in cold water, air-dried, and apposed to an autoradiography imaging plate, exposed overnight, and analyzed as described above.
Histological Analyses
Histological features of plaques were studied in aortic tissue sections stained with hematoxylin and eosin or Movat pentachrome after autoradiography. Uptake of 18 F-galacto-RGD was compared with the plaque composition in Movat pentachrome stained sections in 34 randomly selected plaques of 8 mice. Proportions of connective tissue (yellow) and ground substance (green) as well as nuclear density were determined using automated image analysis software (Definiens Architect, Munich, Germany). Count densities were determined in the same plaques by drawing the ROI in the autoradiogram of the same or adjacent section.
Macrophages, endothelial cells, B-cells, and T-cells were detected by automated immunostaining (Ventana Medical Systems, Tucson, Ariz) of 8-m serial frozen sections using the following primary antibodies: Mac-3 (BD, Heidelberg, Germany), CD31 (AbD Serotec, clone 390), CD3 (DAKO, Hamburg, Germany), and B220/CD45R (clone RA3-6B2; BD Pharmingen, Heidelberg, Germany), respectively. Biotinylated goat anti-mouse (Dako) or goat anti-rabbit (Vector, Burlingame, Canada) IgG antibodies were used as secondary reagents, linked to a streptavidin-HRP-complex (Jackson Immunoresearch Laboratories, West Grove, Pa) and visualized with diaminobenzidine (DAB) (Sigma-Aldrich, Munich, Germany). The area of Mac-3 positive staining within plaques was visually graded as small, intermediate, or large.
In Vivo Imaging
Four LDLR Ϫ/Ϫ ApoB 100/100 mice and 5 controls were imaged with the Inveon small animal PET/CT scanner (Siemens, Knoxville, Tenn) 75 minutes after injection of 18 F-galacto-RGD. PET images were acquired for 15 minutes followed by CT angiography without moving the animal. To obtain vascular contrast, 0.2 to 0.3 mL of iodinated intravascular contrast agent Fenestra (ART, Advanced Research Technologies, Saint-Laurent, Canada) was injected. CT acquisition consisted of 270 projections acquired with exposure time of 400 ms, x-ray voltage of 80 kVp, and anode current of 400 A for a full 360°rotation. Mice were kept fully sedated with 1.5% isoflurane during injections and imaging.
PET images were reconstructed using OSEM2D algorithm. The resulting matrix was 128ϫ128 pixels with 159 transverse slices in a transaxial field of view of 12.7 cm (pixel size 0.87ϫ0.87ϫ0.80 mm). Data were normalized and corrected for randoms, dead time, and decay. No corrections were made for attenuation or scatter. CT images were reconstructed using a modified Feldkamp algorithm.
The resulting matrix was 256ϫ256 pixels with 384 transverse slices (pixel size 0.17ϫ0.17ϫ0.17 mm).
The PET and CT images were fused and analyzed using the Inveon Research Workplace (Siemens, Knoxville, Tenn). Image registration was done using automatic weighted mutual information algorithm and confirmed visually on basis of anatomic landmarks showing physiological accumulation of the tracer, such as the kidneys, skin, liver, thymus, and bone marrow. For measurement of tracer uptake, ROIs were drawn in the bifurcation of the brachiocephalic artery and the right atrium, as seen in the CT angiogram. Activities were corrected for injected dose to calculate %ID/g and the ratio of vessel-related activity to blood pool.
Statistical Analysis
All results are expressed as meanϮSD. The Dunnett test was used to compare biodistribution of 18 F-galacto-RGD in organs, and the Student t test was used for nonpaired data when comparing the uptake between LDLR Ϫ/Ϫ ApoB 100/100 and control mice. Repeatedmeasures ANOVA with Tukey correction was used to compare tracer uptake in the adventitia, normal vessel wall, and plaques. Linear regression was calculated with a mixed model (mouse as a random factor) for uptake of 18 F-galacto-RGD, uptake of 3 H-DG, and histological features. Normality tests were performed using the Shapiro-Wilkins method. A probability value Ͻ0.05 was considered statistically significant.
Results
All LDLR Ϫ/Ϫ ApoB 100/100 mice had extensive atherosclerotic plaques throughout the aorta. The plaques were characterized by well-defined lipid cores and overlying fibrotic tissue consistent with fibrous cap atheromas (type IV). Occasional calcifications were also seen. Cell infiltration was of mild to moderate degrees. No atherosclerosis was found in the aortas of control mice.
Biodistribution of 18 F-Galacto-RGD
The activity measured 2 hours after injection of 18 F-galacto-RGD was significantly higher in the aortas of LDLR Ϫ/Ϫ ApoB 100/100 mice than in aortas of C57Bl/6N control mice (Table) . The %ID/g in the aorta was more than 2 times higher than the residual activity in the blood of the same mice (PϽ0.0001). In addition to the aorta, the activity was higher in the liver of LDLR Ϫ/Ϫ ApoB 100/100 than control mice.
Uptake of 18 F-Galacto-RGD in Atherosclerotic Plaques
Uptake of 18 F-galacto-RGD to the vessel wall of LDLR Ϫ/Ϫ ApoB 100/100 mice was studied by autoradiography of longitudinal aortic tissue sections. The uptake showed a patchy pattern with highest signal intensities corresponding to atherosclerotic lesions as shown in Figure 1 . Average uptake of 18 F-galacto-RGD was significantly higher in the atherosclerotic plaques than in the adjacent normal vessel wall or adventitia. Mean PSL/mm 2 was 55Ϯ10 in the plaques, 39Ϯ6 in the normal vessel wall, and 37Ϯ7 in the adventitia ( Figure  1 ). Peak plaque-to-normal vessel wall ratios in the animals varied from 1.7 to 3. The uptake in the aorta of C57Bl/6N controls was comparable to that in the normal vessel wall of LDLR Ϫ/Ϫ ApoB 100/100 .
Correlation to Histology
Histological correlates of 18 F-galacto-RGD uptake were studied in serial tissue sections stained with hematoxylin and eosin, Movat pentachrome, and immunohistochemistry, as shown in Figure 1 . Immunohistochemical staining with CD31 demonstrated a strong positive signal in the endothelial lining of the aorta ( Figure 1E ). However, neoangiogenesis was nearly absent in the plaques ( Figure 1H ). Instead, uptake of 18 F-galacto-RGD was associated with density of nuclei in the atherosclerotic plaques (Figure 2A ). The highest uptake was seen in the lesions with the highest density of nuclei as quantified in the Movat stained sections. Based on the results of the immunohistochemical analyses, most of the cells in the plaques, approximately 60%, were macrophages ( Figure 1G and 1I). Nuclear density was associated with macrophage number as indicated by higher density in the plaques graded as having large (nϭ8) than small (nϭ11) Mac-3-positive area (2.1Ϯ1.2 versus 1.0Ϯ0.3 a.u., Pϭ0.01). Only very few T-cells or B-cells were found (not shown). In contrast to cellularity, there was no association between 18 F-galacto-RGD uptake and either the size of the lipid core or amount of connective tissue as seen in the analysis of the Movat-stained sections ( Figure 2B and 2C) .
In Vitro Binding of 18 F-Galacto-RGD in Mouse Aorta Sections
The presence of 18 F-galacto-RGD binding sites in the atherosclerotic plaques was verified in an in vitro binding and displacement study shown in Figure 3 . 18 F-galacto-RGD was found to bind to the atherosclerotic lesions and the binding was efficiently reduced in the presence of an unlabeled cyclic RGD peptide. The ratio of specific to nonspecific binding was on average 9-fold.
Comparison of 18 F-Galacto-RGD and 3 H-DG
The in vivo accumulation of 3 H and 18 F activities were measured in the same ROIs in each aortic section. There was an association between uptakes of 3 H-DG and 18 F-galacto-RGD (Figure 4 ) in the atherosclerotic plaques. Highest uptakes of both tracers were found in the same plaques. When normalized to uptake in the muscle, 3 H-DG activity was higher than that of 18 F-galacto-RGD in the atherosclerotic plaques (4.0Ϯ1.6 versus 1.7Ϯ0.5, Pϭ0.02) but also in the normal vessel wall (2.7Ϯ1.0 versus 1.3Ϯ0.5, Pϭ0.01) and adventitia (5.2Ϯ2.9 versus 1.3Ϯ0.4, Pϭ0.03). Thus, plaqueto-normal vessel wall ratios of tracers were comparable (1.4 versus 1.3, respectively).
In Vivo Imaging
In vivo imaging demonstrated focal 18 F-galacto-RGD signal that colocalized with calcified atherosclerotic lesions of the aortic arch, as seen in the CT angiogram ( Figure 5 ) and histology (Figure 1) . The average ratio of 18 F-galacto-RGD signal in the bifurcation of the brachiocephalic artery to blood was 1.5Ϯ0.2 in the LDLR Ϫ/Ϫ ApoB 100/100 mice and 1.1Ϯ0.1 in controls (Pϭ0.02). The corresponding %ID/g was 0.24Ϯ0.07 and 0.14Ϯ0.08, respectively. Peak vessel-toblood ratios in the hypercholesterolemic mice were 2.0Ϯ0.3 and corresponding peak %ID/g, 0.32Ϯ0.09.
Discussion
We demonstrate that 18 F-galacto-RGD shows focal, specific uptake in atherosclerotic plaques in the aorta of hypercholesterolemic LDLR Ϫ/Ϫ ApoB 100/100 mice. In this model, 18 Fgalacto-RGD uptake was highest in plaques with high prevalence of macrophages. Consistent with this, uptakes of 3 H-deoxyglucose and 18 F-galacto-RGD were highest in the same atherosclerotic plaques. Imaging of ␣ v ␤ 3 integrin expression in atherosclerotic plaques by 18 F-galacto-RGD PET is a potential strategy for in vivo visualization of inflammation in atherosclerotic lesions.
18
F-Galacto-RGD Uptake in Atherosclerotic Plaques
18 F-galacto-RGD is a tracer that is based on the cyclic pentapeptide cyclo(-Arg-Gly-Asp-D-Phe-Val-). 11, 19 It shows high affinity and selectivity for ␣ v ␤ 3 integrin in vitro 11 as well as receptor-type specific accumulation in vivo in ␣ v ␤ 3 integrin-positive tumors in mouse models 11 and humans. 13 It has favorable kinetic properties for imaging, such as high initial retention in the blood, rapid renal excretion, and high metabolic stability. 11, 12, 19 Expression of ␣ v ␤ 3 integrin is an interesting target for molecular imaging of atherosclerosis because it is highly expressed in the macrophages and neovessels in plaques. 14, 15 Both macrophages and angiogenesis have been implicated in progression and rupture of atherosclerotic lesions. 2, 3, 7 However, ␣ v ␤ 3 integrin can also be expressed by smooth muscle cells in the media of normal and diseased arteries. 14 A previous study used ␣ v ␤ 3 integrin-targeted nanoparticles that showed enhancement in MRI signal throughout the wall of cholesterol-fed rabbit aorta with a mild degree of intimal thickening. 16 In the study of Burtea et al, 22 a newly characterized low-molecular peptidomimetric of RGD grafted to gadolinium-DTPA showed MRI enhancement of predominantly external layers of the atherosclerotic abdominal aortic vessel wall of ApoE Ϫ/Ϫ mice.
Our study provides the first evidence that ␣ v ␤ 3 integrintargeted tracer, 18 F-galacto-RGD, shows specific accumulation in advanced, spontaneous atherosclerotic lesions seen in LDLR Ϫ/Ϫ ApoB 100/100 mice. A systematic analysis demonstrated higher 18 F-galacto-RGD uptake in the atherosclerotic plaques than in the normal vessel wall. In line with this, the results of the biodistribution study showed quantitatively higher uptake in the aorta of atherosclerotic than control mice. The efficient blocking of 18 F-galacto-RGD in in vitro competition studies confirmed that binding was ␣ v ␤ 3 integrin-dependent and indicate that 18 Figure 4 . Dual-tracer autoradiography revealed an association between uptake of 18 F-galacto-RGD and 3 H-deoxyglucose in the same atherosclerotic plaques (Pϭ0.0036, n (ROI)ϭ96, A). When normalized to muscle, deoxyglucose uptake (black bars) was higher than that of 18 F-galacto-RGD (gray bars) in both the plaques and normal vessel wall (B). However, the plaque-tonormal wall ratios of tracer activities were comparable. specifically detect ␣ v ␤ 3 integrin expression in atherosclerotic lesions.
Histological Basis of Uptake
Histological analysis demonstrated that uptake of 18 Fgalacto-RGD was associated with nuclear density in the plaques. Immunohistochemistry demonstrated that nuclear density reflected mainly the prevalence of macrophages, which was by far the most common cell type in the plaques. In contrast to cellularity, 18 F-galacto-RGD uptake did not show any association to either the amount of fibrous tissue or ground substance representing mainly the lipid core of the plaques. The results are in line with the study of Waldeck et al, 23 demonstrating that another ␣ v ␤ 3 integrin-targeted RGD peptide labeled for optical imaging colocalized with macrophages in the vascular lesions induced by carotid artery ligation in ApoE Ϫ/Ϫ mice. Unlike our tracer, this probe allowed exact colocalization studies on cellular level using fluorescence microscopy of tissue sections. 23 The possibility for detection of ␣ v ␤ 3 integrin expression on macrophages of atherosclerotic lesions makes 18 F-galacto-RGD an attractive tracer for identification of sites of highly inflamed atherosclerotic process. In addition to serving as a marker of macrophage density, ␣ v ␤ 3 integrin may be directly involved in the degradation of the protective fibrous cap of atherosclerotic lesions because it has been identified as a binding moiety that localizes protease activity to the cell surface. 24, 25 However, its role in atherosclerosis remains to be elucidated in more detail. 26 The ␣ v ␤ 3 integrin is perhaps best known for its essential role as a mediator of angiogenesis. 27 In 2 previous studies, enhancement of atherosclerotic vessel wall by ␣ v ␤ 3 integrintargeted tracers was explained by the presence of angiogenic vessels around the intima. 16, 23 Furthermore, signal intensity was attenuated by therapeutic inhibition of angiogenesis with fumagillin. 28 In contrast to those studies, we found virtually no evidence of angiogenesis within the plaques despite old age and prolonged cholesterol feeding of the animals. This is consistent with previous studies demonstrating very limited intraplaque neovascularization in mice. 29 -31 Therefore, it appears that neovascularization had little influence of uptake of 18 F-galacto-RGD in the atherosclerotic plaques in this model. The fact that 18 F-galacto-RGD uptake did not differ between adventitia and the normal vessel wall in either LDLR Ϫ/Ϫ ApoB 100/100 or control mice also indicates that vasa vasorum expansion outside the plaques did not significantly contribute to the detected 18 F-galacto-RGD uptake. Notably, the nanoparticle used in the study of Winter et al 16 is likely to prefer binding sites directly accessible to the blood vessels, whereas 18 F-galacto-RGD may penetrate into the plaques due to its small molecular weight. Because intraplaque neovascularization has been reported in human atherosclerotic plaques, studies on 18 F-galacto-RGD uptake on such plaques are warranted in the future. 2, 7 However, because angiogenesis and inflammation typically coexist in atherosclerotic lesions and share the same signaling mechanisms, it may be difficult to separate their exact contributions to 18 F-galacto-RGD uptake. 30 18 F-FDG PET is currently the best-characterized approach for imaging plaque inflammation. Therefore, we compared 18 Fgalacto-RGD uptake with 3 H-DG, an analogue of 18 F-FDG, by coinjection and dual-tracer autoradiography. Although uptake of 3 H-DG appeared to be higher in the aorta, the ratio between plaque and normal vessel wall was comparable between tracers. Consistent with the results of our histological study demonstrating an association between 18 F-galacto-RGD uptake and macrophage density, 18 F-galacto-RGD and 3 H-DG activities were also associated in the same plaques. Compared with 18 F-galacto-RGD, 3 H-DG uptake in the plaques showed wider range of variation that may indicate that 3 H-DG provides better distinction of plaques with different amount of macrophages. However, lack of uptake of 18 F-galacto-RGD in the normal myocardium may be an important feature if the aim is imaging of coronary arteries.
Comparison to Deoxyglucose
In Vivo Visualization of Uptake of 18 
F-Galacto-RGD in Atherosclerotic Lesions
Combining high sensitivity of nuclear imaging with PET with the anatomic detail provided by CT in hybrid imaging has the potential to map signal to atherosclerotic vascular lesions in mice and humans. 32, 33 Previous studies have demonstrated that 18 F-galacto-RGD PET visualized tumors with high levels of ␣ v ␤ 3 integrin expression with good signal-to-background ratios. 12 More recent studies have indicated sufficient signal intensity for visualizing increased ␣ v ␤ 3 integrin expression in chronic skin inflammation 34 and infarcted myocardium. 35, 36 As expected, %ID/g of 18 F-galacto-RGD in the aorta was severalfold lower than in ␣ v ␤ 3 integrin-expressing tumors. However, autoradiography demonstrated that the maximal plaqueto-normal vessel wall ratios were as high as 3. In vivo imaging with a small-animal PET/CT scanner demonstrated 18 F-galacto-RGD PET signal corresponding to the advanced calcified plaques of the aortic arch region. In parallel with the in vivo signal, autoradiography showed the highest plaqueto-normal vessel wall ratios typically in the arch region, particularly in the bifurcation of the brachiocephalic artery. Calcification in advanced atherosclerotic lesions allowed localization of the vessel wall in CT angiography. However, no uptake in the calcification itself was detected in autoradiography. Although partial volume effects related to small size of the target are likely to influence quantitative analyses, our results provide evidence that visualization of ␣v␤3 integrin expression in atherosclerotic lesions is possible using 18 Fgalacto-RGD PET. Considering the relatively moderate level of inflammation and lack of neovascularization in the plaques in our model, these results encourage testing of 18 F-galacto-RGD for imaging atherosclerosis in patients in whom plaques with high degrees of inflammation and possibly neovascularization may provide stronger signal than that seen in our study. Furthermore, tracer optimization by multimerization has been shown to provide increases in signal intensity from ␣ v ␤ 3 integrin-expressing tissues. 37 Similar to 18 F-FDG or nanoparticles for MRI, 18 F-galacto-RGD is readily testable in humans, based on the experiences from several studies involving cancer patients facilitating application to clinical studies.
Study Limitations
It remains controversial whether mice have true vulnerable atherosclerotic plaque and therefore 18 F-galacto-RGD must be studied in other conditions showing high levels of inflammation and neovascularization.
Autoradiography analysis of very small structures such as healthy vessel wall is challenging and causes variation in results that was compensated by analyzing regions in serial sections adding the effect of multiple measurements.
Conclusions
We demonstrate that 18 F-galacto-RGD shows focal, specific uptake in atherosclerotic plaques in the aorta of hypercholesterolemic mice. In this model, 18 F-galacto-RGD uptake was highest in plaques with dense cell infiltrate composed mainly of macrophages. Uptake ratios between plaque and normal vessel wall were comparable to those of deoxyglucose. 18 F-galacto-RGD is a potential tracer for imaging vascular inflammation. Further studies are needed to characterize its uptake in plaques with high degrees of inflammation and neovascularization.
